Trials / Completed
CompletedNCT05918354
Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies
Development and Evaluation of an Artificial Intelligence Model to Support Read Out of Skin Prick Automated Test Results for the Diagnosis of Aeroallergies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 993 (actual)
- Sponsor
- Hippocreates · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To improve accuracy and take out human error, Hippo Dx previously developed S.P.A.T., an automated skin prick test. Now, Hippo Dx will develop and evaluate a S.P.A.T. artificial intelligence (AI) medical software to support physicians in the read out of the test results from an automated skin prick test. In this study 700 images will be collected to develop the AI model, an additional 200 images will be collected to evaluate performance of the AI model. In a last independent cohort of 100 patients, performance of read-out by the physician will be compared with read out by the physician supported by the S.P.A.T. AI medical software. The primary endpoint is the accuracy of the maximal wheal size measurement by S.P.A.T. AI versus the maximal wheal size measurement by the physician. It is a prospective multicentric study that will include 1000 study participants from different countries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Skin Prick Automated Test | Detection of sensitisation to specific allergens via the skin prick automated test. |
Timeline
- Start date
- 2023-07-10
- Primary completion
- 2024-09-11
- Completion
- 2024-09-11
- First posted
- 2023-06-26
- Last updated
- 2024-10-16
Locations
6 sites across 2 countries: Belgium, Germany
Source: ClinicalTrials.gov record NCT05918354. Inclusion in this directory is not an endorsement.